We recently demonstrated the presence of caveolae in human airway smooth muscle (ASM) and the contribution of caveolin-1 to intracellular calcium ([Ca 2ϩ ]i) regulation. In the present study, we tested the hypothesis that caveolin-1 regulates ASM contractility. We examined the role of caveolins in force regulation of porcine ASM under control conditions as well as TNF-␣-induced airway inflammation. In porcine ASM strips, exposure to 10 mM methyl-␤-cyclodextrin (CD) or 5 M of the caveolin-1 specific scaffolding domain inhibitor peptide (CSD) resulted in time-dependent decrease in force responses to 1 M ACh. Overnight exposure to the cytokine TNF-␣ (50 ng/ml) accelerated and increased caveolin-1 expression and enhanced force responses to ACh. Suppression of caveolin-1 with small interfering RNA mimicked the effects of CD or CSD. Regarding mechanisms by which caveolae contribute to contractile changes, inhibition of MAP kinase with 10 M PD98059 did not alter control or TNF-␣-induced increases in force responses to ACh. However, inhibiting RhoA with 100 M fasudil or 10 M Y27632 resulted in significant decreases in force responses, with lesser effects in TNF-␣ exposed samples. Furthermore, Ca 2ϩ sensitivity for force generation was substantially reduced by fasudil or Y27632, an effect even more enhanced in the absence of caveolin-1 signaling. Overall, these results indicate that caveolin-1 is a critical player in enhanced ASM contractility with airway inflammation. caveolae; lung; inflammation; cytokine; MAP kinase; RhoA; small interfering RNA CAVEOLAE, FLASK-SHAPED PLASMA membrane invaginations rich in cholesterol and sphingolipids, express any of three caveolin proteins (caveolin-1, caveolin-2, and/or caveolin-3). By virtue of caveolar expression of agonist receptors, ion channels, and other membrane proteins, as well as the association of caveolins with intracellular proteins, the role of caveolins as organizers and facilitators of signal transduction is now well recognized (12, 23, 38, 62, 67, 81, 82) .
CAVEOLAE, FLASK-SHAPED PLASMA membrane invaginations rich in cholesterol and sphingolipids, express any of three caveolin proteins (caveolin-1, caveolin-2, and/or caveolin-3). By virtue of caveolar expression of agonist receptors, ion channels, and other membrane proteins, as well as the association of caveolins with intracellular proteins, the role of caveolins as organizers and facilitators of signal transduction is now well recognized (12, 23, 38, 62, 67, 81, 82) .
Multiple studies including our own (16, 28, 33, 61, 68, 73) , have now demonstrated the presence of caveolae and caveolins in airway smooth muscle (ASM). However, their role in ASM biology is still under investigation. One potential role for caveolins is regulation of intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ). In ASM, elevation of [Ca 2ϩ ] i by bronchoconstrictors such as acetylcholine (ACh) or histamine involves both sarcoplasmic reticulum (SR) Ca 2ϩ release and plasma membrane Ca 2ϩ influx (2, 11, 46, 54, 60) . We and others have reported that ASM plasma membrane fractions enriched in caveolae contain several Ca 2ϩ regulatory proteins including agonist receptors and plasma membrane Ca 2ϩ influx channels (16, 61) . Furthermore, in vascular smooth muscle, caveolae are in close proximity to the SR, a key component of [Ca 2ϩ ] i regulation in smooth muscle. Consistent with these structural findings, we and others have shown that caveolins do regulate [Ca 2ϩ ] i in ASM, especially that via Ca 2ϩ influx resulting from SR Ca 2ϩ release (16, 28, 61) . Airway inflammation underlies the pathophysiological changes seen in asthma and airway hyperreactivity. Increased ASM contractility in the inflamed airway is responsible, at least in part, for the pathological airway narrowing and increased resistance to airflow in these diseases. Airway inflammation induced by cytokines such as tumor necrosis factor (TNF-␣) has been demonstrated to involve a variety of pathways such as RhoA as well as MAP kinases (40) . Although a role for caveolins in inflammation in general and lung inflammation in particular has also been suggested (27, 39, 51) , the specific involvement of ASM has not been examined from a functional standpoint. In other smooth muscle types (e.g., vascular, gallbladder, and intestine), the role of caveolins in force regulation has been described (15, 19, (57) (58) (59) 70) . However, there is very little information in regard to the role of caveolins in force regulation in ASM, beyond the finding in canine ASM strips that caveolar disruption decreases the sensitivity of force (but not maximum isometric force) to ACh stimulation (31) . The underlying mechanisms are also not known. However, when examining cell proliferation, previous studies have reported caveolin regulation of p42/44 MAP kinase (30) as well as RhoA and Rho kinase signaling (73) . These signaling pathways are also relevant to airway inflammation and may contribute to the increased contractility of the inflamed airway.
In the present study, we hypothesized that caveolin-1 regulates ASM contractility, and we examined the role of caveolins in force regulation of the porcine ASM under control conditions as well as TNF-␣-induced airway inflammation.
MATERIALS AND METHODS
Force measurement in ASM strips. Porcine trachea were obtained from a local abattoir and immersed in chilled physiological salt solution (PSS) containing (in mM) 110.5 NaCl, 25.7 NaHCO 3, 5.6 dextrose, 3.4 KCl, 2.4 CaCl 2, 1.2 KH2PO4, 0.8 MgSO4. Fat, connective tissue, and epithelium were removed with tissue forceps and scissors. The smooth muscle layer was carefully dissected and cut into equal-sized strips, ϳ0.5-1 mm ϫ 3-6 mm in size. One strip was used per vertical organ bath (Radnotti 5-ml organ bath), with multiple samples evaluated simultaneously.
Experiments were performed in PSS bubbled with 95% O 2 and 5% CO 2 at an initial temperature of 37°C (see below regarding other protocols). Samples were immobilized at one end, and the other end attached by a thin metal rod to a Grass FT03 force transducer (Grass Instruments) connected to an electronic amplifier (World Precision Instruments). Data were collected by use of a custom-built software program (LabView, National Instruments) and a data acquisition card (National Instruments) at 1 Hz.
Samples were stretched to optimal length using repeated contractions via 1 M ACh with intermittent washes. In one set of experiments, following an initial ACh contraction at optimal length, tissues were incubated with 10 mM methyl-␤-cyclodextrin (CD; cholesterol chelator that disrupts caveolae; Ref. 61 ) for 2 h, 4 h or 24 h. Time control samples were exposed to medium only for the same time periods. In another set of experiments, strips at optimal length (where ACh contractions were verified) were exposed to 50 ng/ml TNF-␣ overnight at 4°C. Following overnight TNF-␣ exposure, strips were slowly warmed to 37°C, contracted with 1 M ACh again, washed, and then exposed to 10 mM CD for 2 h or 4 h. Three sets of controls were used in this protocol: one set was exposed to medium only overnight (instead of TNF-␣) and then exposed to CD as above (ϪTNF-␣ control). The other set was exposed to TNF-␣ overnight, but not to CD the following day (ϪCD control). A third set samples was initially contracted with 1 M ACh, washed, and then left in medium for up to 28 h to verify lack of tissue degradation (time control).
The above experiments were intended to demonstrate the role of caveolae based on the idea of cholesterol depletion by CD. To demonstrate the role of caveolin-1 per se, in an additional set of experiments in control (ϪTNF-␣ control) as well as TNF-␣-exposed strips, instead of CD, 5 M of a caveolin-1 specific caveolin scaffolding domain peptide (CSD, Enzo Life Sciences International, Plymouth Meeting, PA) was used. Samples were exposed to CSD for 6 h to inhibit the function of caveolin-1. Additional quality control studies involved the use of a negative-CSD (Calbiochem, La Jolla, CA) that has no caveolin-1 inhibitory function. All samples were finally flash frozen in liquid nitrogen for Western blot analysis.
Reverse permeabilization and transfection with caveolin-1 siRNA. Mounted porcine ASM strips were transfected in situ in the organ bath by using 50 nM small interfering RNA (siRNA) through the method of reverse permeabilization, previously described (76, 77) . Suppression of caveolin expression in ASM by using siRNAs was also recently described (61) . Briefly, siRNA duplex corresponding to bovine caveolin-1 or 2 mRNA targeting the open reading frame of human caveolin-1 mRNA (223-241 bases; 5=-CCA GAA GGA ACA CAC AGU U-dTdT-3=; negative control siRNA 5=-GCG CGC UUU GUA GGA UUC G-dTdT-3=) (Dharmacon, Lafayette, CO). In initial studies, we found considerable suppression of caveolin-1 in porcine ASM by using these siRNA constructs. For the transfection, briefly, ASM strips were mounted and stretched to optimal length as described above. The strips were then incubated successively in each of the following solutions: solution 1 (4°C, 120 min) containing 10 mM EGTA, 5 mM Na2ATP, 120 mM KCl, 2 mM MgCl2, 20 mM TES; solution 2 (4°C, overnight) containing 0.1 m EGTA, 5 mM Na 2ATP, 120 mM KCl, 2 mM MgCl 2, 20 mM TES, and siRNA (caveolin-1 siRNA as well as negative siRNA for our experiments); solution 3 (4°C, 30 min) containing 0.1 m EGTA, 5 mM Na2ATP, 120 mM KCl, 10 mM MgCl 2, 20 mM TES; and solution 4 (22°C, 60 min) containing 110 mM NaCl, 3.4 mM KCl, 0.8 mM MgSO 4, 25.8 mM NaHCO3, 1.2 mM KH 2PO4, and 5.6 mM dextrose. Solutions 1-3 were maintained at pH 7.1 and aerated with 100% O 2. Solution 4 was maintained at pH 7.4 and was aerated with 95% O2-5% CO2. After 30 min in solution 4, CaCl2 was added gradually to reach a final concentration of 2.4 mM and organ baths were slowly reheated to 37°C. After completion of the reverse permeabilization, strips were recontracted with 1 M ACh and force responses compared with responses before the reverse permeabilization. All samples were finally flash frozen in liquid nitrogen for Western blot analysis.
Preparation of caveolar membranes. Caveolin-rich membranes were prepared from ASM tissue by previously described methods (61, 79) . Briefly, ASM strips were homogenized in cold buffer A (0.25 M sucrose, 1 mM EDTA, and 20 mM Tricine, pH 7.8), layered onto a 30% Percoll gradient, and centrifuged at 84,000 g for 30 min. Following extraction of the plasma membrane fraction, the volume was brought up to 2 ml with buffer A. This crude membrane fraction was sonicated (5 s each ϫ3), resuspended in a 23% solution of OptiPrep, and placed in a centrifuge tube. A linear 20% to 10% OptiPrep gradient was layered on top and centrifuged (52,000 g for 90 min). The upper membrane layer containing caveolae was collected for further experimentation. Fraction purity was verified by the presence of caveolins, but the absence of proteins specific to SR (e.g., SR Ca 2ϩ ATPase) or mitochondria (cytochrome c).
Western blot analysis. Proteins were separated by SDS-PAGE using a Criterion Gel System (Bio-Rad, Hercules, CA) and 4 -15% gradient or 15% gels. Proteins were transferred to polyvinylidene fluoride membranes (Bio-Rad) for 60 min and then blocked for 1 h with 5% milk in Tris-buffered saline containing 0.1% Tween (TBST). Membranes were then incubated overnight at 4°C with caveolin 1-3 antibodies, ERK and p-ERK antibodies or a RhoA antibody depending on the experimental protocol. Following three washes with TBST, primary antibodies were detected with horseradish peroxidase-conjugated secondary antibodies and signals were developed by Supersignal West Pico Chemiluminescent Substrate (Pierce Chemical, Rockford, IL).
␣-Toxin permeabilization and Ca 2ϩ sensitivity measurements. ASM strips 0.5-0.6 mm wide were cut, mounted in 500-l horizontal organ bath (Guth Muscle Research Systems), and perfused with PSS. Strips were stretched to optimal length with repeated ACh contractions as above. The samples were then treated for 20 min with 2,500 U/ml Staphylococcus aureus ␣-toxin at 25°C. Permeabilization with ␣-toxin allows smaller molecules and ions to diffuse across the plasma membrane (allowing for control of [Ca 2ϩ ]i by altering perfusate Ca 2ϩ ) but preserves membrane receptor-coupled mechanisms and other proteins necessary for contraction. Solutions of varying free [Ca 2ϩ ] (pCa, negative log Ca 2ϩ ) were prepared by using the Fabiato algorithm (20) . Relaxing solution was prepared by using the algorithm of Fabiato and Fabiato (21): 7.5 mM MgATP, 4 mM EGTA, 20 mM imidazole, 1 mM dithiothreitol, 1 mM Mg 2ϩ , 1 nM Ca 2ϩ , 10 mM creatine phosphate, and 0.1 mg/ml creatine phosphokinase. Ionic strength was kept constant at 200 mM by adjusting the concentration of potassium acetate, and pH adjusted to 7.0 at 25°C. The Ca 2ϩ ionophore A23187 (10 M) was added to deplete SR Ca 2ϩ stores. After permeabilization, strips were stimulated by perfusion with increasing concentration of pCa solutions (pCa 7 up to pCa 5) all in the presence of 1 M ACh.
Materials. CD and other chemicals were obtained from SigmaAldrich (St. Louis, MO) unless mentioned otherwise. Primary and secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), except for mouse monoclonal anti-caveolin-1 (BD Transduction Laboratories, Franklin Lakes, NJ) and anti-caveolin-2 (Abcam, Cambridge, MA).
Statistical analysis. All experimental sets were repeated at least three times with ASM samples taken from at least five animals. Drug effects were compared across the same set of strips per tissue by ANOVA with Bonferroni correction for repeated comparisons. Statistical significance was established at P Ͻ 0.05. All values are expressed as means Ϯ SE.
RESULTS
Caveolin expression in porcine ASM. Western blot studies ( Fig. 1) showed that caveolar fractions of porcine ASM express caveolin-1, but not caveolin-2 and caveolin-3. Overnight exposure to TNF-␣ significantly increased caveolin-1 expression, whereas incubation of strips with 10 mM CD for 4 h signifi-cantly decreased caveolin-1 expression (Fig. 1A ). Caveolin-2 and caveolin-3 expression was still absent in the presence of TNF-␣ overnight (Fig. 1B) , even when tested in ASM lysates instead of caveolar fractions. Specificity and applicability of caveolin-2 and caveolin-3 antibodies for porcine proteins were verified by using appropriate extracts from pig heart. Based on these findings, further studies focused only on caveolin-1.
Effect of caveolin suppression on force responses to agonist. Stimulation with 1 M ACh produced a typical, sustained force response in porcine ASM, with force returning to baseline with washout of the agonist. Representative tracings are shown in Fig. 2A . In strips that were maintained in media only (time controls), force responses to 1 M ACh after a 2, 4, or 24 h were ϳ130 -140% of that during the initial contraction (Fig.  2B) . In contrast, incubation of strips with 10 mM CD for 2, 4, or 24 h demonstrated a time-dependent decrease in force responses, with partial decrease at 2 h and almost complete abolishment of the force response by 24 h ( Fig. 2B ; P Ͻ 0.05 for each time point compared with time control and for 4 and 24 h compared with the 2-h value).
Using reverse permeabilization (see MATERIALS AND METHODS), we introduced caveolin-1 siRNA into ASM strips (Fig. 3) . Transfection with caveolin-1 siRNA significantly decreased the force responses to 1 M ACh compared with time control and transfection control (Lipofectamine or nonsense siRNA) strips.
Western blot analysis of the strips found that caveolin-1 expression was significantly reduced by its siRNA, compared with Lipofectamine only or nonsense siRNAs (Fig. 3B) . Smooth muscle-specific myosin served as a loading control for these samples.
TNF-␣ effects on caveolin expression and force. Incubation of ASM strips with 50 ng/ml TNF-␣ overnight significantly enhanced force responses to ACh compared with time controls (Fig. 4B) . Incubation of these TNF-␣-exposed strips subsequently with 10 mM CD for 2 or 4 h resulted in a timedependent decrease in force responses ( Fig. 4B ; P Ͻ 0.05). At either time point, the effect of CD on TNF-␣-exposed strips was comparable to the effect of CD alone (Fig. 4B) . Fig. 2 . Effect of caveolar depletion on contractility of epithelium-denuded ASM strips. In ASM strips mounted in an organ bath and stretched to optimal length, exposure to 1 M ACh (arrowhead) resulted in a typical maintained contraction, with return of force to baseline upon washout of the agonist. Preexposure to 10 mM of the cholesterol chelator CD for even 2 or 4 h resulted in substantial reduction in force production upon subsequent ACh stimulation. Overnight (24 h) exposure to CD considerably reduced ACh-induced force (with complete abolishment in some cases), whereas time-control samples showed sustained force levels. Western analysis of these ASM samples demonstrated time-dependent decrease in caveolin-1 levels. Values are means Ϯ SE. *Significant CD effect (P Ͻ 0.05). Western blot analysis of ASM strips used for force studies above showed a significant increase in caveolin-1 expression following TNF-␣ exposure, compared with vehicle only. Whereas 2 h of CD incubation did not affect caveolin-1 expression in TNF-␣-exposed strips, 4 h of CD significantly decreased caveolin-1 expression ( Fig. 4A ; P Ͻ 0.05).
In another set of experiments, strips were exposed to either 5 M CSD or negative CSD after incubation with TNF-␣. Although exposure to CSD significantly reduced force responses to ACh (P Ͻ 0.05), negative CSD had no effect (Fig. 4C) .
Effects of MAP kinase inhibition on force responses. Following an initial contraction with ACh, ASM strips were washed and incubated in 10 M PD98059 (MAP kinase inhibitor) for 30 min. Compared with time control strips, force responses to ACh after PD98059 exposure were not significantly different (Fig. 5A) . Strips incubated overnight with 50 ng/ml TNF-␣ demonstrated a significant increase in force responses to ACh (as above). Incubation of TNF-␣-exposed strips with PD98059 also did not significantly affect force responses to ACh (Fig. 5) .
Western analyses of the above samples for ERK1/2 expression and phosphorylation were performed (Fig. 5B) . These Fig. 4 . Role of caveolin-1 in TNF-␣-induced modulation of ASM contractility. Western analysis of the ASM samples from force measurements below (A) demonstrated increased caveolin-1 levels following TNF-␣ exposure, whereas CD substantially decreased caveolin-1 levels. Following an initial evaluation of force response to 1 M ACh, ASM strips at optimal length were exposed overnight to 50 ng/ml TNF-␣. Samples were then exposed to 10 mM CD for 0 (control), 2 h or 4 h (B), or 5 M caveolin-1 specific scaffolding domain inhibitor peptide (CSD) or negative (Neg) CSD for 6 h (C), after which force responses to ACh were reevaluated. Overnight exposure to TNF-␣ substantially increased force responses whereas CD reversed this effect (with 4 h exposure reducing force to below control levels). Exposure to CSD significantly reduced force responses whereas negative CSD had no effect. Values are means Ϯ SE. #TNF-␣ effect. *Significant CD effect. @Significant CSD effect (P Ͻ 0.05). Fig. 3 . Effect of caveolin-1 suppression on ASM contractility. In ASM strips at optimal length, following an initial evaluation of force response to 1 M ACh (arrowhead), samples were transfected with a small interfering RNA (siRNA) targeting caveolin-1, vehicle only, or a nonsense (NS) siRNA (see MATERIALS AND METHODS for details). Following overnight transfection, samples were recontracted with ACh. Vehicle alone did not substantially blunt the force response compared with pretransfection values. Nonsense siRNA resulted in a small and insignificant reduction in force. In contrast, caveolin-1 siRNA significantly blunted the force response, indicating a role for caveolin-1 in force production by ASM. Western analysis of these ASM samples demonstrated decrease in caveolin-1 levels by the caveolin-1 siRNA. Values are means Ϯ SE. *Significant siRNA effect (P Ͻ 0.05). sm-Myosin, smooth muscle-specific myosin. studies showed that exposure to PD98059 alone significantly reduced p-ERK levels compared with controls. However, treatment with CD, CSD, or caveolin-1 siRNA alone did not significantly reduce p-ERK expression, compared with control. Overnight TNF-␣ exposure significantly increased p-ERK expression (as expected). However, TNF-␣ in the presence of PD98059 displayed reduced p-ERK levels. CD, CSD, or caveolin-1 siRNA treatment in these TNF-␣-exposed strips did not show an effect on p-ERK compared with TNF-␣ alone (Fig. 5B) . ERK phosphorylation by TNF-␣, and inhibition of phosphorylation by PD98059, indicated that the lack of PD98059 effect on force was unlikely to be a result of inadequate time or inhibitor concentration. Exposure to CD, CSD, caveolin-1 siRNA, or 10 M PD98059 did not significantly affect ERK1/2 expression ( Fig. 5B ; P Ͻ 0.05).
Role of caveolar RhoA in force responses. Western blot analysis of caveolar membrane fractions demonstrated an increase in RhoA expression in the presence of 1 M ACh, confirming plasma membrane translocation ( Fig. 6A ; P Ͻ 0.05). This effect was further enhanced in the presence of TNF-␣. In the presence of 10 mM CD, 5 M CSD, or caveolin-1 siRNA RhoA expression was significantly decreased (P Ͻ 0.05).
Porcine ASM strips were incubated for 1 h with 100 M fasudil or 10 M Y-27632 and force responses to ACh evaluated. Compared with time control strips, samples incubated with fasudil or Y-27632 displayed significantly smaller force responses (Fig. 6 , B and C; P Ͻ 0.05 for each inhibitor). Additional preexposure to CD (for fasudil) or CSD (for Y-27632) resulted in even greater reduction in force (P Ͻ 0.05). The effect of Y-27632 was generally smaller than that of fasudil. Overnight TNF-␣ exposure resulted in increased force Following an initial contraction with ACh, ASM strips at optimal length (previously exposed overnight to medium or TNF-␣) were exposed to 10 M PD98059 (MAP kinase inhibitor) for 30 min (A). Compared with time controls, force responses to ACh after PD98059 were not significantly different. Similarly, enhanced force in strips incubated with TNF-␣ was not significantly affected. Western blot analyses for ERK1/2 expression and phosphorylation showed that exposure to CD, CSD, caveolin-1 (Cav-1) siRNA (B), or PD98059 alone reduced p-ERK levels compared with controls. TNF-␣ significantly increased p-ERK expression, whereas PD98059 reduced p-ERK levels. CD as well as CSD and caveolin-1 siRNA treatment in these TNF-␣-exposed strips did not show an effect on p-ERK compared with TNF-␣ alone. Values are means Ϯ SE. #TNF-␣ effect. $Significant PD98059 effect (P Ͻ 0.05).
response to ACh (as expected). Both fasudil and Y-27632 decreased force responses in TNF-␣-exposed strips albeit to a lesser extent than in samples not exposed to TNF-␣. Additional presence of CD or CSD in TNF-␣-exposed strips resulted in further reduction in force (Figs. 6 , B and C; P Ͻ 0.05).
Effect of caveolar suppression on Ca 2ϩ sensitivity. In ␣-toxin permeabilized ASM strips, sequential exposure to increasing Ca 2ϩ concentrations (decreasing pCa solutions) in the presence of 1 M ACh resulted in a progressive increase in force. Preexposure of (intact) ASM strips to 10 mM CD for 1 h prior to permeabilization resulted in a significantly blunted force-pCa curve ( Fig. 7A ; P Ͻ 0.05). Similarly, preexposure to 100 M fasudil blunted the subsequent force-pCa response in permeabilized strips. Combined exposure to CD and fasudil resulted in a greatly diminished force-pCa response ( Fig. 7A ; P Ͻ 0.05 compared with control, CD, or fasudil alone).
In another set of experiments, 5 M CSD was used to test the role of caveolin-1 per se and 10 M Y-27632 instead of fasudil. Exposure to Y-27632 significantly reduced force responses to increasing Ca 2ϩ concentrations (as with fasudil). CSD significantly blunted the force-pCa curve ( Fig. 7B , P Ͻ 0.05). The combination of Y-27632 and CSD substantially diminished the force responses ( Fig. 7B , P Ͻ 0.05), to an extent comparable to that observed with fasudil and CD (Fig. 7A) .
DISCUSSION
Previous studies (including our own) have demonstrated the presence of caveolae and caveolins in ASM of different species (16, 28, 33, 61, 68, 73) . Studies in other cells have shown that caveolae contain proteins that are important not only for [Ca 2ϩ ] i signaling but also contraction and cellular proliferation (15, 19, (57) (58) (59) 70) . However, there is very little known in regard to the role of caveolins in force regulation in ASM. In the present study, we demonstrate that caveolin-1 is present in the plasma membrane of porcine ASM. We further demonstrate that disruption of caveolae by cyclodextrins significantly decreases isometric force responses to ACh. Using a reverse permeabilization method, we show a significant reduction in force responses to ACh in ASM tissues treated with caveolin-1 siRNA. Exposure to the proinflammatory cytokine TNF-␣ increases force responses to ACh, whereas disruption of caveolae by CD or inhibition of caveolin-1 function using siRNA or CSD blunts this effect. We further demonstrate that the effects of both caveolin-1 and TNF-␣ on force regulation do not involve MAP kinase but do involve the RhoA pathway. Overall, these results highlight a role for caveolin-1 in enhanced airway contractility following inflammation.
Caveolae and caveolins in ASM. Caveolae are 50-to 100-nm flask-shaped plasma membrane invaginations (55, 84) enriched in cholesterol, sphingolipids, and integral membrane proteins called caveolins. Caveolin-enriched plasma membrane domains can bind other proteins via caveolin scaffolding domains (13, 81) , thus facilitating regulation of signaling mechanisms at the plasma membrane and beyond. Of the three mammalian caveolin isoforms (21-24 kDa), caveolin-1 is thought to be fairly ubiquitous, caveolin-2 is usually associated with caveolin-1, and caveolin-3 is thought to be expressed in skeletal and cardiac muscles (12, 66, 74, 81) . Although vascular smooth muscle cells express all three caveolin isoforms (34, 75), albeit with a lower level of caveolin-3 (17) , in previous studies we and others have found that human and canine ASM cells (as well as tissues) express caveolin-1 and -2, but not caveolin-3 (16, 30, 33, 61) . In the present study, we did not find caveolin-2 or -3 expression in porcine ASM (whereas positive controls such as porcine heart continued to show caveolin-2 as well as caveolin-3). The finding of absent caveolin-2 is not entirely without precedent and has been reported in canine ASM (31) . However, the implications of the absence of caveolin-2 in ASM remain to be determined, since caveolin-2 is associated with caveolin-1 and can modulate functionality of the latter.
Caveolae and force regulation in ASM. ] i responses to bronchoconstrictor agonist (61) . However, less is known regarding caveolae and force regulation.
Studies in other cell types have suggested a role for caveolin-1 in coordination of mechanisms involved in smooth muscle contractility (3, 32) . For example, in vascular smooth muscle, where tone can be feedback regulated by subsarcolemmal SR Ca 2ϩ release via spontaneous transient outward currents (42, 52), caveolar invaginations can enhance physical approximation between plasma membrane channels and SR proteins (49) , thus facilitating functional interactions. Accordingly, spontaneous outward currents are reduced in vascular smooth muscle of caveolin-1 knockout mice (18) . In caveolin-1 knockout mice, studies of contractility of vascular (1, 18, 23, 34, 44, 48, 62, 69) and urogenital (83) smooth muscle have shown that absence of caveolin-1 impairs contraction. In contrast, caveolin-1 knockout mice develop severe pulmonary hypertension (18, 62) , although, given the critical importance of caveolae in regulation of endothelial nitric oxide, these findings do not necessarily reflect worsening of smooth muscle contractility in the pulmonary circuit. Regardless, these data generally link caveolae with contractility.
There is little known regarding the role of caveolins in force regulation in ASM. In canine ASM strips, Gosens et al. (31) found that caveolar disruption decreases the sensitivity of force (but not maximum isometric force) to ACh stimulation. However, the underlying mechanisms were not investigated. Our present study suggests that as with vascular smooth muscle, caveolin-1 plays an important role in force regulation in porcine ASM since caveolar disruption either by using CD or introducing caveolin-1 siRNA into muscle strips results in significant decreases in agonist-induced force production. An obvious mechanism for these effects may simply be decreased [Ca 2ϩ ] i responses to bronchonconstrictor agonist, as demonstrated in human ASM cells in our previous study (61) -independent mechanisms (i.e., Ca 2ϩ sensitization) (71) . In this regard, agonist stimulation is known to increase myofilament Ca 2ϩ sensitivity (4, 6, 8, 26, 63) via the monomeric GTP binding protein, RhoA, and its downstream target, Rho kinase (6, 8, 26) , which phosphorylates and inhibits myosin light chain phosphatase, thus maintaining MLC phosphorylation and contraction. Rho kinase inhibition by fasudil or Y-27632 is known to relax ASM (9, 78) . In this regard, the present study reports novel findings that following ACh stimulation, RhoA translocates into lipid rafts, thus facilitating Ca 2ϩ sensitization. This is evidenced by the caveolar location of RhoA upon stimulation and the decreased force production by ASM strips in the presence of fasudil or Y-27632. Accordingly, factors that modulate caveolar expression or signaling can potentially influence ASM contractility via modulating RhoA translocation and activation (e.g., cyclic nucleotides).
Airway inflammation and caveolae. Increased airway narrowing is a hallmark symptom of clinically important diseases such as asthma (24, 25, 37, 43, 45, 47, 50) . The potential role of caveolae and their constituent caveolin proteins in regulation of [Ca 2ϩ ] i and force in ASM in health and diseases such as asthma and airway inflammation is an emerging area of research. Altered levels of caveolins or absence of caveolae have been found in certain diseases (22, 32) . In human ASM cells, Hunter and Nixon (41) demonstrated that lipid rafts or caveolae are essential for TNF-␣-mediated effects. D'Alessio et al. (14) demonstrated the localization of the TNF-␣ receptor within caveolae in human endothelial cells. However, in these studies, the functional role of caveolae was not examined. In this regard, the results of our study are novel. We demonstrate that exposure to TNF-␣ not only greatly increases the expression of caveolin-1 but also enhances force production.
In this regard, caveolin-1 modulation of TNF-␣ effects may occur through two mechanisms: enhanced [Ca 2ϩ ] i and increased contraction beyond Ca 2ϩ . We previously found that caveolae contain proteins important for [Ca 2ϩ ] i regulation such as transient receptor potential channels and Orai1 (61) that are known to be increased in inflammation (80) . Our present findings with CSD in the presence of TNF-␣ support the idea of an additional role for caveolin-1 in modulating Ca 2ϩ sensitivity as well. These observations may appear to be in contrast to a study by Gosens et al. (30) investigating the role of caveolins in airway inflammation with regard to ASM cell proliferation. In that study decreased caveolin-1 was found to increase cell proliferation, whereas our data indicate that decreased caveolin-1 decreases contractility. However, we interpret the results of the two studies to suggest that caveolin-1 expression is associated with maintenance of contractile phenotype. Indeed, such a conclusion was reached by the same group that suggested that in cultured human ASM cells, caveolin-1 promotes phenotype maturation (29) . Furthermore, in in vivo studies using guinea pigs challenged with allergen, caveolin-1 expression and contractile protein expression have been found to be increased (29) . Accordingly, increased caveolin-1, for example as induced by TNF-␣, should contribute to increased contraction.
Mechanisms of caveolar action. Regarding the mechanisms by which caveolae could influence force regulation, studies in several cell types have demonstrated that caveolin-1 modulates signaling cascades relevant to [Ca 2ϩ ] i , force and cell proliferation (35, 56, 69) . For example, Gosens et al. (30) reported that in human ASM cells, disruption of caveolae using CD or caveolin-1 siRNA promotes p42/p44 MAPK activation and increased cell proliferation, thus concluding that normally caveolin-1 suppresses MAP kinase. In this regard, the results of the present study are interesting. We found p42/p44 activation (i.e., phospho-ERK) in control ASM tissues following cholinergic stimulation where caveolin-1 was known to be expressed. However, depletion of caveolae by using CD actually resulted in decreased ERK activation (rather than an increase). TNF-␣, a known activator of MAP kinases, substantially enhanced ERK activation. Accordingly, we expected removal of caveolae to further enhance this effect, based on the previous study by Gosens et al. However, this was not the case. Furthermore, the suppressing effect of PD98059 confirmed that ERK activation was being induced by ACh or TNF-␣. The reason for the discrepancy between the two studies is not clear. However, it should be pointed out that Gosens study was conducted in (human) ASM cells where cellular proliferation was likely high, compared with ASM strips as in the present study.
There is increasing recognition that RhoA/Rho kinase contributes to dysfunctional contractility of several vascular beds (e.g., coronary and cerebral vasospasm, hypertension) (53, 72) . A few studies in ASM have also identified Rho kinase as a novel mechanism involved in increased ASM contractility (5, 7, 10, 40) . Furthermore, inhibition of Rho kinase decreases airway inflammation (36) as well as airway hyperresponsiveness (30, 64, 65) . The relevance of the RhoA/Rho kinase pathway to caveolae lies in the fact that 1) caveolins are thought to be essential for cytokine-induced activation of this pathway (41); and 2) caveolin effects on the RhoA/Rho kinase pathway could modulate force in ASM. The results of the present study showing Rho kinase inhibition (fasudil and Y-27632) decreasing ASM Ca 2ϩ sensitivity and CD or CSD enhancing fasudil and Y-27632 effects on Ca 2ϩ sensitivity are consistent with this idea.
In conclusion, the results of the present study demonstrate that caveolae, and caveolin-1, regulate ASM contractility beyond [Ca 2ϩ ] i , by enhancing RhoA activation, but not via altered MAP kinase signaling. Enhanced ASM contractility following exposure to the proinflammatory cytokine TNF-␣ appears to involve TNF-␣-induced increase in caveolin-1 expression and its subsequent downstream effects on Ca 2ϩ sensitivity as well as [Ca 2ϩ ] i . Methodological issues. An alternative approach to interfering specifically with caveolin-1 would have been the use of siRNAs via the reversible permeabilization technique. However, in pilot studies, we found that given the extended length of time for the protocol where samples had to be exposed to TNF-␣, siRNAs and other drugs, tissue degradation was a concern, even with the use of lower temperatures during the permeabilization procedure. Therefore, we opted to limit the TNF-␣ aspect of our study to CSD only.
